Clinical Trial Update: Study to Investigate the Irritation Potential of GSK1940029 Gel [Phase 1]

View source ↗

Summary

A Phase 1 trial completed to assess the irritation potential of GSK1940029 Gel in acne vulgaris patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• GSK1940029 Gel (GSK1940029)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED